Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3028238 | Thrombosis Research | 2008 | 8 Pages |
Abstract
Ligands interacting with α-helix F of PAI-1 demonstrated a potential for the protection of APC from inactivation by PAI-1. Since the mechanism of proteinase/serpin interaction is universal, a similar design and approach could be employed for enhancing the inactivation of other serpins in order to preserve APC activity in the circulation. Rational pharmacological targeting of the inhibitors of APC could have therapeutic utility.
Keywords
mAbDICscFvtPASingle chain Fv fragmentAPCNBDPAI-1PCIRCLuPAα1-antitrypsinα1ATMonoclonal antibodystoichiometry of inhibitionDIC, Disseminated intravascular coagulationReactive center loopSepsisurokinase type plasminogen activatorplasminogen activator inhibitor 1Plasminogen activator inhibitor-1VitronectinMonoclonal antibodiesProtein C inhibitorActivated protein C
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Andrey A. Komissarov, Peter A. Andreasen, Paul J. Declerck, Yuichi Kamikubo, Aiwu Zhou, András Gruber,